Stakeholder Listening Session in Preparation for the 71st World Health Assembly; Meeting, 19566-19567 [2018-09348]

Download as PDF sradovich on DSK3GMQ082PROD with NOTICES 19566 Federal Register / Vol. 83, No. 86 / Thursday, May 3, 2018 / Notices the Secretaries of Defense and Veterans Affairs, to convene the Task Force no later than two years after the date of the enactment of CARA (by July 22, 2018) and develop a report to Congress with updates on best practices and recommendations on addressing gaps or inconsistencies for pain management, including chronic and acute pain. The Task Force is governed by the provisions of the Federal Advisory Committee Act (FACA), Public Law 92– 463, as amended (5 U.S.C. App), which sets forth standards for the formation and use of advisory committees. The Task Force will identify, review, and determine whether there are gaps or inconsistencies between best practices for pain management, including chronic and acute pain, developed or adopted by federal agencies; propose updates to best practices and recommendations on addressing identified gaps or inconsistencies; provide the public with an opportunity to comment on any proposed updates and recommendations; and develop a strategy for disseminating such proposed updates and recommendations to relevant federal agencies and the general public. This inaugural meeting of the Task Force will consist of an overview of various topics surrounding pain management, and the establishment of the Task Force subcommittee structure. Federal, state, local, and professional medical and health organization representatives will provide their current perspectives on pain management. The Task Force will discuss clinical best practices, gaps and inconsistencies focused on prevention and treatment; mental health and addiction; special populations; education; providers; payors; service and delivery; and research and innovation. Personal testimonials of people living in pain will be given. The Task Force will deliberate and vote on establishing subcommittees for developing the report to Congress. Information about the final meeting agenda will be posted prior to the meeting on the Task Force website: https://www.hhs.gov/ash/advisorycommittees/pain/. Members of the public are invited to participate in person or by webcast. To join the meeting, individuals must preregister at the Task Force website at https://www.hhs.gov/ash/advisorycommittees/pain/. Seating will be provided first to those who have pre-registered. Anyone who has not preregistered will be accommodated on a first come, first served basis if additional seats are available 10 minutes before the meeting starts. Individuals VerDate Sep<11>2014 17:29 May 02, 2018 Jkt 244001 who need special assistance, such as sign language interpretation or other reasonable accommodations, should indicate the special accommodation when registering online or by notifying the Office of the Assistant Secretary for Health via email at paintaskforce@ hhs.gov by May 22, 2018. The subject line of the email should read, ‘‘Task Force Meeting Accommodations.’’ NonU.S. citizens who plan to attend in person are required to provide additional information and must notify the Task Force staff via email at paintaskforce@hhs.gov 10 business days before the meeting, May 16, 2018. For those unable to attend in person, a live webcast will be available. More information on registration and accessing the webcast can be found at https://www.hhs.gov/ash/advisorycommittees/pain/. Members of the public can provide comments at the Task Force meeting during the following designated dates and times: May 30, 2018 from 11:40 a.m. to 12:10 p.m. Eastern Time and May 31, 2018 from 1:50 p.m. to 2:20 p.m. Eastern Time. Public comments made during the meeting will be limited to three minutes per person to ensure time is allotted for all those wishing to speak. Individuals are also welcome to submit their written comments. Written comments should not exceed three pages in length. Individuals submitting written comments should submit their comments through the Federal eRulemaking Portal at https:// www.regulations.gov by May 25, 2018. Dated: April 26, 2018. Vanila M. Singh, Chief Medical Officer, Office of the Assistant Secretary for Health. [FR Doc. 2018–09379 Filed 5–2–18; 8:45 am] BILLING CODE 4150–28–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Stakeholder Listening Session in Preparation for the 71st World Health Assembly; Meeting Subject: Office of Global Affairs: Stakeholder Listening Session in preparation for the 71st World Health Assembly Time and date: Friday, May 11th, 2018, 3:00 p.m.–4:30 p.m. EST Place: Hubert H. Humphrey Building, Auditorium, 200 Independence Ave, SW, Washington, District of Columbia 20201. Status: Open, but requiring RSVP to OGA.RSVP@hhs.gov by Monday, May 7, 2018. PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 Purpose: The U.S. Department of Health and Human Services (HHS)— charged with leading the U.S. delegation to the 71st World Health Assembly— will hold an informal Stakeholder Listening Session on Friday, May 11 from 3:00 p.m. to 4:30 p.m., in the Hubert H. Humphrey Building Auditorium, 200 Independence Ave. SW, Washington, DC 20201. The Stakeholder Listening Session will help the HHS Office of Global Affairs prepare the U.S. delegation for the World Health Assembly by taking full advantage of the knowledge, ideas, feedback, and suggestions from all individuals interested in and affected by agenda items to be discussed at the 71st World Health Assembly. Participants will be limited to 3 minute statements per agenda item. Your input will contribute to informing U.S. positions as we negotiate with our international colleagues at the World Health Assembly on these important health topics. The listening session will be organized by agenda item, and participation is welcome from all individuals, including individuals familiar with the following topics and groups: • Public health and advocacy activities; • State, local, and Tribal issues; • Private industry; • Minority health organizations; and • Academic and scientific organizations. All agenda items to be discussed at the 71st World Health Assembly can be found at this website: https:// apps.who.int/gb/ebwha/pdf_files/ WHA71/A71_1-en.pdf RSVP: Due to security restrictions for entry into the HHS Hubert H. Humphrey Building, RSVPs are required for this event. Please send your full name and organization to OGA.RSVP@hhs.gov . Please RSVP no later than Monday, May 7, 2018. If you are not a U.S. citizen and do not have a U.S. government issued form of identification, please note this in the subject line of your RSVP, and our office will contact you to gain additional biographical information required for your clearance. Photo identification for all attendees is required for building access without exception. Written comments are welcome and encouraged, even if you are planning on attending in person. Please send your written comments to OGA.RSVP@ hhs.gov. We look forward to hearing your comments related to the 71st World Health Assembly agenda items. E:\FR\FM\03MYN1.SGM 03MYN1 Federal Register / Vol. 83, No. 86 / Thursday, May 3, 2018 / Notices Dated: April 25, 2018. G. Garrett Grigsby, Director for Global Affairs. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health [FR Doc. 2018–09348 Filed 5–2–18; 8:45 am] Center for Scientific Review; Notice of Closed Meetings BILLING CODE 4150–38–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Initial Review Group Biobehavioral and Behavioral Sciences Subcommittee. Date: June 11, 2018. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Minki Chatterji, Scientific Review Officer, Scientific Review Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS 6710B Rockledge Drive, Rm. 2121D, Bethesda, MD 20892–7501, 301–827–5435, minki.chatterji@nih.gov. sradovich on DSK3GMQ082PROD with NOTICES (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: April 27, 2018. Michelle D. Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–09354 Filed 5–2–18; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 17:29 May 02, 2018 Jkt 244001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Bioengineering Sciences & Technologies Integrated Review Group; Nanotechnology Study Section. Date: May 30–31, 2018. Time: 7:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Nikko San Francisco, 222 Mason Street, San Francisco, CA 94102. Contact Person: James J Li, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5148, MSC 7849, Bethesda, MD 20892, 301–806–8065, lijames@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–18– 011: Early Phase Clinical Trials in Imaging and Image-Guided Interventions. Date: May 30, 2018. Time: 3:30 p.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Songtao Liu, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5118, Bethesda, MD 20817, 301–827–6828, songtao.liu@nih.gov. Name of Committee: Surgical Sciences, Biomedical Imaging and Bioengineering Integrated Review Group; Biomedical Imaging Technology A Study Section. Date: May 31–June 1, 2018. Time: 7:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: DoubleTree by Hilton Hotel St. Louis—Westport, 1973 Craigshire Rd, St. Louis, MO 63146. Contact Person: Ruth Grossman, DDS, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5215, Bethesda, MD 20892, (301) 435–2409, grossmanrs@mail.nih.gov. Name of Committee: Digestive, Kidney and Urological Systems Integrated Review Group; PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 19567 Clinical, Integrative and Molecular Gastroenterology Study Section. Date: May 31, 2018. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Lorien Hotel & Spa, 1600 King Street, Alexandria, VA 22314. Contact Person: Jonathan K Ivins, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2190, MSC 7850, Bethesda, MD 20892, (301) 594– 1245, ivinsj@csr.nih.gov. Name of Committee: Musculoskeletal, Oral and Skin Sciences Integrated Review Group; Skeletal Biology Structure and Regeneration Study Section. Date: May 31–June 1, 2018. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance Harborplace Hotel, 202 East Pratt Street, Baltimore, MD 21202. Contact Person: Yanming Bi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4214, MSC 7814, Bethesda, MD 20892, 301–451– 0996, ybi@csr.nih.gov. Name of Committee: Interdisciplinary Molecular Sciences and Training Integrated Review Group; Enabling Bioanalytical and Imaging Technologies Study Section. Date: May 31–June 1, 2018. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: The Westin St. Francis, 335 Powell Street, San Francisco, CA 94102. Contact Person: Kenneth Ryan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3218, MSC 7717, Bethesda, MD 20892, 301–435– 0229, kenneth.ryan@nih.hhs.gov. Name of Committee: Oncology 1-Basic Translational Integrated Review Group; Cancer Etiology Study Section. Date: May 31–June 1, 2018. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria, VA 22314. Contact Person: Ola Mae Zack Howard, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Dr. Room 4192, MSC 7806, Bethesda, MD 20892, 301–451–4467, howardz@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Nursing and Related Clinical Sciences. Date: May 31–June 1, 2018. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Martha L Hare, RN, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3154, Bethesda, MD 20892, (301) 451–8504, harem@mail.nih.gov. E:\FR\FM\03MYN1.SGM 03MYN1

Agencies

[Federal Register Volume 83, Number 86 (Thursday, May 3, 2018)]
[Notices]
[Pages 19566-19567]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-09348]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Stakeholder Listening Session in Preparation for the 71st World 
Health Assembly; Meeting

    Subject: Office of Global Affairs: Stakeholder Listening Session in 
preparation for the 71st World Health Assembly
    Time and date: Friday, May 11th, 2018, 3:00 p.m.-4:30 p.m. EST
    Place: Hubert H. Humphrey Building, Auditorium, 200 Independence 
Ave, SW, Washington, District of Columbia 20201.
    Status: Open, but requiring RSVP to [email protected] by Monday, May 
7, 2018.
    Purpose: The U.S. Department of Health and Human Services (HHS)--
charged with leading the U.S. delegation to the 71st World Health 
Assembly--will hold an informal Stakeholder Listening Session on 
Friday, May 11 from 3:00 p.m. to 4:30 p.m., in the Hubert H. Humphrey 
Building Auditorium, 200 Independence Ave. SW, Washington, DC 20201.
    The Stakeholder Listening Session will help the HHS Office of 
Global Affairs prepare the U.S. delegation for the World Health 
Assembly by taking full advantage of the knowledge, ideas, feedback, 
and suggestions from all individuals interested in and affected by 
agenda items to be discussed at the 71st World Health Assembly. 
Participants will be limited to 3 minute statements per agenda item. 
Your input will contribute to informing U.S. positions as we negotiate 
with our international colleagues at the World Health Assembly on these 
important health topics.
    The listening session will be organized by agenda item, and 
participation is welcome from all individuals, including individuals 
familiar with the following topics and groups:
     Public health and advocacy activities;
     State, local, and Tribal issues;
     Private industry;
     Minority health organizations; and
     Academic and scientific organizations.
    All agenda items to be discussed at the 71st World Health Assembly 
can be found at this website: https://apps.who.int/gb/ebwha/pdf_files/WHA71/A71_1-en.pdf
    RSVP: Due to security restrictions for entry into the HHS Hubert H. 
Humphrey Building, RSVPs are required for this event. Please send your 
full name and organization to [email protected] . Please RSVP no later 
than Monday, May 7, 2018.
    If you are not a U.S. citizen and do not have a U.S. government 
issued form of identification, please note this in the subject line of 
your RSVP, and our office will contact you to gain additional 
biographical information required for your clearance. Photo 
identification for all attendees is required for building access 
without exception.
    Written comments are welcome and encouraged, even if you are 
planning on attending in person. Please send your written comments to 
[email protected].
    We look forward to hearing your comments related to the 71st World 
Health Assembly agenda items.


[[Page 19567]]


    Dated: April 25, 2018.
G. Garrett Grigsby,
 Director for Global Affairs.
[FR Doc. 2018-09348 Filed 5-2-18; 8:45 am]
BILLING CODE 4150-38-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.